Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...

But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

This week, Merck filed a notice in accordance with New Jersey's WARN Act, indicating it plans to eliminate 58 positions at ...

Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in patients with muscle-invasive bladder cancer when administered before and ...

Merck in 2019 inked a deal to evaluate the combination of its blockbuster cancer drug Keytruda with Pacdev from Astellas and Seagen, which Pfizer acquired in a $43 billion deal that closed in late ...